Insights

Innovative Therapeutics SENISCA is pioneering a new generation of oligonucleotide-based therapeutics targeting cellular senescence, positioning it to capitalize on the growing market for age-related disease treatments and rejuvenation solutions.

Strong Funding & Recognition The company has secured notable investments, including GBP 3.7M and GBP 571,350 from Innovate UK, along with a recent $4.72M funding round, indicating strong investor confidence and financial stability suitable for expansion of sales efforts.

Leadership & Strategic Growth Recent leadership appointments, including a new Chair of the Board and an experienced CEO, suggest a strategic focus on scaling operations and establishing key industry partnerships to enhance market penetration.

Recent Industry Engagements SENISCA has gained media attention and industry recognition through awards and news mentions, which can be leveraged in marketing to attract biotech partners, research collaborations, and early adopters in the therapeutics space.

Targeted Market Development Focusing on developing therapeutics for diseases like idiopathic pulmonary fibrosis positions SENISCA to target niche biotech and pharmaceutical companies seeking innovative age-related and lung disease treatments, opening up tailored sales opportunities.

SENISCA Tech Stack

SENISCA uses 8 technology products and services including TRUENDO, Google Fonts API, Google Tag Manager, and more. Explore SENISCA's tech stack below.

  • TRUENDO
    Cookie Compliance
  • Google Fonts API
    Font Scripts
  • Google Tag Manager
    Tag Management
  • YouTube
    Video Players
  • Adobe Fonts
    Web Fonts
  • DigitalOcean Web Hosting
    Web Hosting
  • Apache HTTP Server
    Web Servers
  • Apache
    Web Servers

Media & News

SENISCA's Email Address Formats

SENISCA uses at least 1 format(s):
SENISCA Email FormatsExamplePercentage
First.Last@senisca.comJohn.Doe@senisca.com
48%
First.Middle@senisca.comJohn.Michael@senisca.com
2%
Fir.Last@senisca.comJoh.Doe@senisca.com
2%
First.Last@senisca.comJohn.Doe@senisca.com
48%

Frequently Asked Questions

Where is SENISCA's headquarters located?

Minus sign iconPlus sign icon
SENISCA's main headquarters is located at Barrack Road Exeter, England United Kingdom. The company has employees across 3 continents, including EuropeNorth AmericaSouth America.

What is SENISCA's official website and social media links?

Minus sign iconPlus sign icon
SENISCA's official website is senisca.com and has social profiles on LinkedInCrunchbase.

What is SENISCA's SIC code NAICS code?

Minus sign iconPlus sign icon
SENISCA's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does SENISCA have currently?

Minus sign iconPlus sign icon
As of March 2026, SENISCA has approximately 21 employees across 3 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Executive Officer: S. C.Chief Development Officer (cdo): T. S. S.Head Of Discovery Research: B. L.. Explore SENISCA's employee directory with LeadIQ.

What industry does SENISCA belong to?

Minus sign iconPlus sign icon
SENISCA operates in the Biotechnology Research industry.

What technology does SENISCA use?

Minus sign iconPlus sign icon
SENISCA's tech stack includes TRUENDOGoogle Fonts APIGoogle Tag ManagerYouTubeAdobe FontsDigitalOcean Web HostingApache HTTP ServerApache.

What is SENISCA's email format?

Minus sign iconPlus sign icon
SENISCA's email format typically follows the pattern of First.Last@senisca.com. Find more SENISCA email formats with LeadIQ.

When was SENISCA founded?

Minus sign iconPlus sign icon
SENISCA was founded in 2020.

SENISCA

Biotechnology ResearchEngland, United Kingdom11-50 Employees

SENISCA is a biotech spinout company from the University of Exeter, founded in 2020 and dedicated to the development of new approaches to reverse cellular senescence (senotherapeutics).

Our founders are world leaders in molecular and cellular biology and have patent-protected an innovation for the reversal of cellular senescence. This innovation works by restoring the ability of cells to ‘fine tune’ the expression of their genes to rejuvenate aged cells.

At SENISCA, we are using this knowledge, concerning how and why cells become senescent, to develop a new generation of oligonucleotide-based interventions, to turn back the ageing clock in old cells and to target the diseases and aesthetic signs of ageing.

Section iconCompany Overview

Headquarters
Barrack Road Exeter, England United Kingdom
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    SENISCA's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    SENISCA's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.